| |
|
NEWS
|
Nov. 21, 2011
MOLOGEN attains the goals of the renal cancer study with MGN1601 ahead of schedule
 the press release
|
|
Nov. 18, 2011
MOLOGEN AG appoints Dr. Stefan M. Manth to the scientific advisory board
the press release
|
NEWSLETTER |
| To receive our press releases please
click here |
|
|
GENE
THERAPY